Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone

References

• MeltzerHYCognitive factors in schizophrenia: causes, impact, and treatmentCNS Spectr2004910 Suppl 11152415475873
   PubMed Web of Science ®Google Scholar
• HarveyPDMeltzerHSimpsonGMImprovement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophreniaSchizophr Res2004662–310111315061242
   PubMed Web of Science ®Google Scholar
• WoodwardNDPurdonSEMeltzerHYZaldDHA meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophreniaInt J Neuropsychopharmacol20058345747215784157
   PubMed Web of Science ®Google Scholar
• KernRSGreenMFCornblattBAThe neurocognitive effects of aripiprazole: an open-label comparison with olanzapinePsychopharmacology (Berl)2006187331232016810506
   PubMed Web of Science ®Google Scholar
• KeefeRSSweeneyJAGuHEffects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparisonAm J Psychiatry200716471061107117606658
   PubMed Web of Science ®Google Scholar
• HoriHYoshimuraRKatsukiAThe cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patientsJ Psychiatr Res201246675776122464338
   PubMed Web of Science ®Google Scholar
• KeeKSHoranWPSaloveyPEmotional intelligence in schizophreniaSchizophr Res20091071616818805674
   PubMed Web of Science ®Google Scholar
• KernRSGreenMFFiskeAPTheory of mind deficits for processing counterfactual information in persons with chronic schizophreniaPsychol Med200939464565418694537
   PubMed Web of Science ®Google Scholar
• HarveyPOLeeJHoranWPOchsnerKGreenMFDo patients with schizophrenia benefit from a self-referential memory bias?Schizophr Res20111271–317117721147520
   PubMed Web of Science ®Google Scholar
• LeeJZakiJHarveyPOOchsnerKGreenMFSchizophrenia patients are impaired in empathic accuracyPsychol Med201141112297230421524334
   PubMed Web of Science ®Google Scholar
• FettAKViechtbauerWDominguezMDPennDLvan OsJKrabbendamLThe relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysisNeurosci Biobehav Rev201135357358820620163
   PubMed Web of Science ®Google Scholar
• HoranWPGreenMFDeGrootMSocial cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patientsSchizophr Bull201238486587221382881
   PubMed Web of Science ®Google Scholar
• NodaYKurumiyaSMiuraYOkaMComparative study of 2-(4-ethyl-1-piperazinyl)-4-(fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b] pyridine (AD-5423) and haloperidol for their pharmacological activities related to antipsychotic efficacy and/or adverse side-effectsJ Pharmacol Exp Ther199326527457518098763
   PubMed Web of Science ®Google Scholar
• OkaMNodaYOchiYPharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist propertiesJ Pharmacol Exp Ther199326411581658093723
   PubMed Web of Science ®Google Scholar
• DeeksEDKeatingGMBlonanserin: a review of its use in the management of schizophreniaCNS Drugs2010241658420030420
   PubMed Web of Science ®Google Scholar
• OhoyamaKYamamuraSHamaguchiTEffect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortexEur J Pharmacol20116531–3475721147094
   PubMed Web of Science ®Google Scholar
• KishiTMatsudaYNakamuraHIwataNBlonanserin for schizophrenia: systematic review and meta-analysis of double-blind, randomized, controlled trialsJ Psychiatr Res201347214915423131856
   PubMed Web of Science ®Google Scholar
• TenjinTMiyamotoSMiyakeNEffect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophreniaHum Psychopharmacol20122719010022278973
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic Criteria from DSM-IV-TRWashington, DCAmerican Psychiatric Association2000
   Google Scholar
• KaySRFiszbeinAOplerLAThe positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull19871322612763616518
   PubMed Web of Science ®Google Scholar
• KanedaYSumiyoshiTKeefeRIshimotoYNumataSOhmoriTBrief assessment of cognition in schizophrenia: validation of the Japanese versionPsychiatry Clin Neurosci200761660260918081619
   PubMed Web of Science ®Google Scholar
• KeefeRSGoldbergTEHarveyPDGoldJMPoeMPCoughenourLThe Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive batterySchizophr Res2004682–328329715099610
   PubMed Web of Science ®Google Scholar
• KanedaYSumiyoshiTNakagomeKThe brief assessment of cognition in schizophrenia Japanese version (BACS-J)Seishinigaku2008509913917 Japanese
   Google Scholar
• IwasakiSMiyauchiMOshimaIThe development of Life Assessment Scale for the Mentally Ill: an assessment of the reliabilitySeishin Igaku19943611391151 Japanese
   Google Scholar
• IwanamiAYamashinaMKazamatsuriHKamijimaKP300 and disability of daily life in schizophreniaProg Neuropsychopharmacol Biol Psychiatry199923342343010378227
   PubMed Web of Science ®Google Scholar
• InadomiHTanakaGWatanabeSEfficacy of 3-year psychiatric daycare treatment in patients with schizophreniaPsychiatry Clin Neurosci200559324625215896216
   PubMed Web of Science ®Google Scholar
• HoriHYoshimuraRKatsukiASugitaAIAtakeKNakamuraJSwitching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patientsJ Psychiatr Res201347121843184824054464
   PubMed Web of Science ®Google Scholar
• LiebermanRPGutkindDMintzJImpact of risperidone versus haloperidol on activities of daily living in the treatment of refractory schizophreniaCompr Psychiatry200243646947312439835
   PubMed Web of Science ®Google Scholar
• KanedaYOhmoriTImpact of risperidone medication on quality of life and gonadal axis hormones in schizophrenia male patients with acute exacerbationInt J Neuropsychopharmacol20036324725212974991
   PubMed Web of Science ®Google Scholar
• TsutsumiYKasugaYIsakaYEffectiveness of blonanserin (BNS) in 70 in-patients with acute phase schizophreniaJapanese Journal of Clinical Psychopharmacology20111415231540 Japanese
   Google Scholar
• HarveyPDKeefeRSStudies of cognitive change in patients with schizophrenia following novel antipsychotic treatmentAm J Psychiatry2001158217618411156796
   PubMed Web of Science ®Google Scholar